首页> 外国专利> Crystalline form of azide bis(L-arginine)chlorine-copper(Il)bis(L-arginine)diazido-copper(II) hydrate 1/7 complex and method of its production

Crystalline form of azide bis(L-arginine)chlorine-copper(Il)bis(L-arginine)diazido-copper(II) hydrate 1/7 complex and method of its production

机译:叠氮化物双(L-精氨酸)氯-铜(II)双(L-精氨酸)重氮基-铜(II)水合物1/7配合物的结晶形式及其制备方法

摘要

The report concerns the crystalline form of the bis(L-arginine)chloromide(II)bis(L-arginine)diazydomide(II) hydrate 1/7, model 1, used as an antifungal and antibacterial compound. The notification also covers the production of the crystalline form of the bis(L-arginine)chloromides(II)bis(L-arginine)diazydomide(II) hydrate 1/7 complex with formula 1, which is characterised by one molar part of the hydrogenated copper chloride (II) molar salt,is dissolved in water and reacted with two molar parts of the L-arginine solution, the resulting mixture is then reacted with three molar parts of the KN3 aqueous solution and the clear mixture is left to evaporate slowly at room temperature, A crystalline form of bis(L-arginine)chloromides(II)bis(L-arginine)diazydomide(II) hydrate 1/7 with formula 1 is obtained after at least forty days.
机译:该报告涉及模型1的双(L-精氨酸)氯酰亚胺(II)双(L-精氨酸)乙二胺(II)水合物1/7的晶体形式,用作抗真菌和抗菌化合物。该通知还涉及具有式1的双(L-精氨酸)氯代亚胺(II)双(L-精氨酸)乙二酰胺(II)水合物1/7配合物的结晶形式的生产,其特征在于将氢化氯化铜(II)摩尔盐溶解在水中,并与2摩尔份的L-精氨酸溶液反应,然后使所得混合物与3摩尔份的KN3水溶液反应,使澄清的混合物缓慢蒸发在室温下,至少四十天后,获得具有式1的双(L-精氨酸)氯代亚胺(II)双(L-精氨酸)二氢嘧啶(II)水合物1/7的结晶形式。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号